SUPERFLUID DX, INC.

Medtech · Private

NGS-based liquid biopsy platform for detecting circulating cell-free mRNA biomarkers to diagnose Alzheimer's disease and mild cognitive impairment

Grants
$1.9M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
9
1 granted · 8 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's Disease$1,086,079
Federal grantDepartment of Health and Human Services · Phase II · Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's Disease$843,061
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2253NEUROTYPE INC.——
2254ENGINEERING RESOURCES GROUP INC——
2255GLYCIOME, LLC——
2256SUPERFLUID DX, INC.——
2257Cell-Safe Life Sciences LLC——
2258i2C Solutions, LLC——
2259FEMTOVOX INCORPORATED——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 9
  • Systems And Methods Of Detecting Splice Junctions In Extracellular Cell-free Messenger Rnaapplication
  • Methods And Systems For Detecting Tissue Conditionsgranted
  • Systems And Methods Of Detecting A Risk Of Alzheimer's Disease Using A Circulating-free Mrna Profiling Assayapplication
  • Methods And Systems For Detecting Tissue Conditionsapplication
  • Cell-free Rna Library Preparationsapplication
  • Characterization Of Bone Marrow Using Cell-free Messenger-rnaapplication
  • Disease Stratification Of Liver Disease And Related Methodsapplication
  • Systems And Methods Of Detecting Splice Junctions In Extracellular Cell-free Messenger Rnaapplication
  • Systems And Methods Of Detecting Retroviral Transcripts Using Cell-free Messenger Rna Nucleocapsid Sequencingapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.